SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-008832
Filing Date
2021-07-09
Accepted
2021-07-09 07:35:29
Documents
3
Period of Report
2021-07-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210707x8k.htm 8-K 31364
2 EX-99.1 tmb-20210707xex99d1.htm EX-99.1 8918
3 GRAPHIC tmb-20210707xex99d1001.jpg GRAPHIC 5781
  Complete submission text file 0001558370-21-008832.txt   49507
Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Filer) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39746 | Film No.: 211081667
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences